---
title: "MedicQuant ApS – Regnskab 2025 og nøgletal"
description: "MedicQuant ApS (CVR 40732829). Regnskabsperiode: 2025-01-01 – 2025-12-31. Bruttofortjeneste 1,9 mio. DKK, årets resultat -742 t DKK, egenkapital 10 mio. DKK."
canonical_url: "https://datapublica.dk/companies/40732829-medicquant-aps/financials"
locale: "da"
route_type: "company_financials"
robots: "index,follow"
content_access: "standard"
---

# MedicQuant ApS — Regnskab

MedicQuant ApS \(CVR 40732829\). Regnskabsperiode: 2025-01-01 – 2025-12-31. Bruttofortjeneste 1,9 mio. DKK, årets resultat -742 t DKK, egenkapital 10 mio. DKK.

CVR 40732829

## Seneste regnskabsperiode

- 2025 • 2025-01-01 • 2025-12-31 • entity • DKK • 1911164 • -1098767 • -741962 • 11457858 • 10000226 • 7

## Regnskabshistorik

- 2024 • 2024-01-01 • 2024-12-31 • entity • DKK • 1094375 • -1053864 • -501347 • 11446637 • 10742188 • 4

- 2023 • 2023-01-01 • 2023-12-31 • entity • DKK • 1399 • -657580 • -934443 • 11874425 • 11243535 • 3

- 2022 • 2022-01-01 • 2022-12-31 • entity • DKK • -91196 • -266058 • 211682 • -122022 • 2

- 2021 • 2021-01-01 • 2021-12-31 • entity • DKK • 0 • -76578 • -225624 • 75018 • 310669 • 144036

- 2020 • 2019-08-22 • 2020-12-31 • entity • DKK • -103499 • -708987 • -8680 • 231572 • 36318

## Højdepunkter fra årsrapporten

- primary activities • Description of key activities of the companyThe purpose of the company is to develop and manufacture medical devices and reagents for in vitro diagnostic purpose. • entity

- development in activities and financial affairs • Significant changes in the company's activities and financial mattersThe gross profit for the year totals DKK 1.911 thousand against DKK 1.094 thousand last year. Profit or loss from ordinary activities after tax totals DKK -742 thousand against DKK -501 thousand last year.

Financial resourcesAs of the balance sheet date, the company does not have sufficient funds to continue the development of its project. During February 2026, Management has however secured in excess of DKK 22 million to support the continued development of the project towards commercialisation. Based on this, management has prepared the financial statements as a going concern. • entity

- going concern uncertainty • 1.

Financial resourcesAs of the balance sheet date, the company does not have sufficient funds to continue the development of its project. During February 2026, Management has however secured in excess of DKK 22 million to support the continued development of the project towards commercialisation. Based on this, management has prepared the financial statements as a going concern. • entity

- subsequent events • Events occurring after the end of the financial yearApart from the above, no events have occurred after the balance sheet date of material importance to the annual report for 2025. • entity

- contingent liabilities • 10.Contractual obligations and contingencies, etc.

DKK in thousands

Lease liabilities

255

Total contractual obligations

255

Total contingent liabilities

0

Total contractual obligations and contingent liabilities

255

Lease liabilities:

MedicQuant ApS has entered into a rent obligation with a 6 months notice. The total rent

obligation is DKK 255 thousand. • entity